Results 151 to 160 of about 8,908 (223)

Letter to the editor: clinical translation of senolytic immunotherapy: critical considerations for SenoVax™ and beyond. [PDF]

J Transl Med
Xie J, Wang Z, Wang L, Cui M.
europepmc   +1 more source

Cellular Senescence and Anti-Aging Strategies in Aesthetic Medicine: A Bibliometric Analysis and Brief Review

Clinical, Cosmetic and Investigational Dermatology
Huilan Zheng,1 Jingping Wu,2 Jinhong Feng,2 Hongbin Cheng3 1School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, 610075, People’s Republic of China; 2Department of Medical Cosmetology, Hospital of ...
Zheng H, Wu J, Feng J, Cheng H
doaj  

Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance. [PDF]

Nat Aging
Wakita M, Ito K, Fujii K, Sakamoto D, Mikawa T, Sugawara S, Zhou X, Park JH, Miyagawa H, Motooka D, Ogasawara E, Ishihara N, Takahashi A, Kondoh H, Hara E.   +14 more
europepmc   +1 more source

Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities. [PDF]

Front Cell Dev Biol
Lisitsa DA, Shindyapin VV, Nurislamov AR, Demidov ON, Bogdanova DA.   +4 more
europepmc   +1 more source

DEL-1 is an Endogenous Senolytic Protein that Inhibits Senescence-Associated Bone Loss. [PDF]

Adv Sci (Weinh)
Lim JH, Sirisereephap K, Wang H, Trimaglio G, Chung KJ, Korostoff J, Kajikawa T, Li X, Surboyo MDC, Maekawa T, Chavakis T, Hajishengallis G.   +11 more
europepmc   +1 more source

Senotherapeutics in Malignant Brain Cancer Therapy. [PDF]

Curr Oncol Rep
Kaina B, Christmann M.
europepmc   +1 more source

Senotherapeutics for Brain Aging Management. [PDF]

Neurol Int
Saliev T, Singh PB.
europepmc   +1 more source

A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. [PDF]

Ther Adv Med Oncol
Ji J, Crespi CM, Yee L, Zekster YA, Al-Saleem A, Petersen L, Lee C, Son N, Smith C, Evans T, Tchkonia T, Kirkland JL, Kuchel GA, Cohen HJ, Sedrak MS.   +14 more
europepmc   +1 more source

Natural killer cell-based senotherapy: a promising strategy for healthy aging. [PDF]

Front Immunol
Nakazawa T, Yamanishi R, Morimoto T, Matusda R.   +3 more
europepmc   +1 more source

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer. [PDF]

Front Cell Dev Biol
As Sobeai HM, Alanazi AM, Alotaibi F, Alhoshani A, Alhazzani K, Almutairi MM, Almudimeegh S, Al-Ramadi BK, Chakraborty E, Saleh T, Gewirtz DA, Harada H, Alotaibi MR.   +12 more
europepmc   +1 more source